243 related articles for article (PubMed ID: 29374850)
1. Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.
López JI; Angulo JC
Curr Urol Rep; 2018 Jan; 19(1):3. PubMed ID: 29374850
[TBL] [Abstract][Full Text] [Related]
2. Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist.
López JI
APMIS; 2016 Mar; 124(3):153-9. PubMed ID: 26865355
[TBL] [Abstract][Full Text] [Related]
3. Snail heterogeneity in clear cell renal cell carcinoma.
Zaldumbide L; Erramuzpe A; Guarch R; Pulido R; Cortés JM; López JI
BMC Cancer; 2016 Mar; 16():194. PubMed ID: 26951092
[TBL] [Abstract][Full Text] [Related]
4. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma.
Guarch R; Lawrie CH; Larrinaga G; Angulo JC; Pulido R; López JI
Ann Diagn Pathol; 2018 Jun; 34():27-30. PubMed ID: 29661723
[TBL] [Abstract][Full Text] [Related]
5. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Gerlinger M; Rowan AJ; Horswell S; Math M; Larkin J; Endesfelder D; Gronroos E; Martinez P; Matthews N; Stewart A; Tarpey P; Varela I; Phillimore B; Begum S; McDonald NQ; Butler A; Jones D; Raine K; Latimer C; Santos CR; Nohadani M; Eklund AC; Spencer-Dene B; Clark G; Pickering L; Stamp G; Gore M; Szallasi Z; Downward J; Futreal PA; Swanton C
N Engl J Med; 2012 Mar; 366(10):883-892. PubMed ID: 22397650
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in renal cell carcinoma.
Beksac AT; Paulucci DJ; Blum KA; Yadav SS; Sfakianos JP; Badani KK
Urol Oncol; 2017 Aug; 35(8):507-515. PubMed ID: 28551412
[TBL] [Abstract][Full Text] [Related]
7. Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level.
Manini C; López-Fernández E; Lawrie CH; Laruelle A; Angulo JC; López JI
Curr Urol Rep; 2022 Jun; 23(6):93-97. PubMed ID: 35416538
[TBL] [Abstract][Full Text] [Related]
8. Loss of PD-L1 (SP-142) expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma.
López JI; Pulido R; Lawrie CH; Angulo JC
Ann Diagn Pathol; 2018 Jun; 34():89-93. PubMed ID: 29661736
[TBL] [Abstract][Full Text] [Related]
9. [Clinical challenges and implications of intratumor heterogeneity].
Palacios J; Matías-Guiu X; Rodríguez-Peralto JL; de Álava E; López JI
Rev Esp Patol; 2019; 52(4):234-241. PubMed ID: 31530406
[TBL] [Abstract][Full Text] [Related]
10. Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy.
López JI; Pulido R; Cortés JM; Angulo JC; Lawrie CH
Pathol Res Pract; 2018 Aug; 214(8):1110-1114. PubMed ID: 29910061
[TBL] [Abstract][Full Text] [Related]
11. Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous.
Zaldumbide L; Erramuzpe A; Guarch R; Cortés JM; López JI
Virchows Arch; 2015 Jan; 466(1):61-6. PubMed ID: 25369891
[TBL] [Abstract][Full Text] [Related]
12. Towards Personalized Sampling in Clear Cell Renal Cell Carcinomas.
Manini C; López-Fernández E; López JI
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884442
[TBL] [Abstract][Full Text] [Related]
13. Precision sampling fuels precision oncology: an evolutionary perspective.
Manini C; López-Fernández E; López JI
Trends Cancer; 2021 Nov; 7(11):978-981. PubMed ID: 34493466
[TBL] [Abstract][Full Text] [Related]
14. Convergent insights into intratumor heterogeneity.
Manini C; Laruelle A; Rocha A; López JI
Trends Cancer; 2024 Jan; 10(1):12-14. PubMed ID: 37684129
[TBL] [Abstract][Full Text] [Related]
15. A divide-and-conquer strategy in tumor sampling enhances detection of intratumor heterogeneity in routine pathology: A modeling approach in clear cell renal cell carcinoma.
Lopez JI; Cortes JM
F1000Res; 2016; 5():385. PubMed ID: 27127618
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Tumor Eco-Evolution in Renal Cell Carcinoma Sampling.
López-Fernández E; López JI
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30518081
[TBL] [Abstract][Full Text] [Related]
17. CD34 immunostaining enhances a distinct pattern of intratumor angiogenesis with prognostic implications in clear cell renal cell carcinoma.
López JI; Erramuzpe A; Guarch R; Cortés JM; Pulido R; Llarena R; Angulo JC
APMIS; 2017 Feb; 125(2):128-133. PubMed ID: 28120493
[TBL] [Abstract][Full Text] [Related]
18. Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.
Serie DJ; Joseph RW; Cheville JC; Ho TH; Parasramka M; Hilton T; Thompson RH; Leibovich BC; Parker AS; Eckel-Passow JE
Eur Urol; 2017 Jun; 71(6):979-985. PubMed ID: 27899233
[TBL] [Abstract][Full Text] [Related]
19. Words of wisdom. Re: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Tannock IF
Eur Urol; 2014 Apr; 65(4):846-7. PubMed ID: 24559903
[No Abstract] [Full Text] [Related]
20. Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity.
Yuan Q; Kapur P; Zhang Y; Xi Y; Carvo I; Signoretti S; Dimitrov IE; Cadeddu JA; Margulis V; Brugarolas J; Madhuranthakam AJ; Pedrosa I
Clin Genitourin Cancer; 2016 Dec; 14(6):e585-e594. PubMed ID: 27209349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
